Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.6122
+0.00621.02%
Post-market: 0.63500.0228+3.72%19:55 EST
Volume:205.28K
Turnover:126.03K
Market Cap:29.72M
PE:-0.38
High:0.6499
Open:0.6490
Low:0.6000
Close:0.6060
52wk High:2.38
52wk Low:0.5301
Shares:48.54M
Float Shares:35.00M
Volume Ratio:0.61
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.00
PE(LYR):-0.38

Loading ...

Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice

TIPRANKS
·
Yesterday

Werewolf Therapeutics Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Reuters
·
Yesterday

Director Luke Evnin Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Jan 21

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 16

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 13

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 08

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 03

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 30, 2025

Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3

MT Newswires Live
·
Dec 19, 2025

Werewolf Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 19, 2025

BRIEF-Werewolf Therapeutics Inc - Plans For Two Inds By Mid-2027

Reuters
·
Dec 18, 2025

Werewolf Therapeutics Inc - Plans for Two Inds by Mid-2027

THOMSON REUTERS
·
Dec 18, 2025

Werewolf Therapeutics Reports Promising Phase 1 Data for WTX-124 and WTX-330 in Advanced Cancer Trials

Reuters
·
Dec 18, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 18, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 13, 2025

Director Luke Evnin Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 10, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05, 2025

Former 10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

MPM BioVentures 2014 L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025